61269-480 : Valcyte 450 mg Oral Tablet, Film Coated
| NDC: | 61269-480 |
| Labeler: | H2-pharma, LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Valcyte |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA021304 |
| Rev. Date: |
NDC Package Codes:
- 61269-480-60: 1 BOTTLE, PLASTIC IN 1 CARTON (61269‑480‑60) / 60 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC
Active Ingredients:
- Valganciclovir Hydrochloride
Dosage Strength:
- 450 mg
Pharmaceutical Classes:
- Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
- DNA Polymerase Inhibitors [MoA]
- Nucleoside Analog Antiviral [EPC]
- Nucleoside Analog [EXT]
Related Products:
Based on records with the same trade name.- 61269-485 Valcyte 50 mg/ml Oral Powder, for Solution by H2-pharma, LLC
- 0004-0038 Valcyte 450 mg Oral Tablet by Genentech, Inc.
- 0004-0039 Valcyte 50 mg/ml Oral Powder, for Solution by Genentech, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 61269-475Next: 61269-485 >
Related Discussions:
VALCYTE-450MG
IS THERE DANGER TO TAKE A VALCYTE 450 MG/DAY FOR 03 MONTHS IN POST RENAL TRANSPLANT CASES OF CHILD 13 YRS...
IS THERE DANGER TO TAKE A VALCYTE 450 MG/DAY FOR 03 MONTHS IN POST RENAL TRANSPLANT CASES OF CHILD 13 YRS...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.